$SHOT
Safety Shot, Inc. Stock $shot

$shot Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224032325 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$110.2K	$710.2K
YoY Change	-77.24%	-69.97%
Cost Of Revenue	$402.4K	$504.5K
YoY Change	-5.5%	-72.9%
Gross Profit	-$292.2K	$205.7K
YoY Change	-600.46%	-59.16%
Gross Profit Margin	-265.11%	28.96%
Selling, General & Admin	$11.23M	$8.394M
YoY Change	183.41%	325.39%
% of Gross Profit		4080.56%
Research & Development	$10.32K	$119.9K
YoY Change	-83.13%	3072.22%
% of Gross Profit		58.29%
Depreciation & Amortization	$109.0K	$104.5K
YoY Change	50.52%	383.57%
% of Gross Profit		50.8%
Operating Expenses	$11.35M	$8.619M
YoY Change	171.32%	331.21%
Operating Profit	-$11.64M	-$8.413M
YoY Change	182.25%	462.75%
Interest Expense	-$57.92K	-$293.7K
YoY Change	-92.02%	-126.42%
% of Operating Profit
Other Income/Expense, Net	$10.41K	$138.8K
YoY Change	-100.29%	-87.77%
Pretax Income	-$11.63M	-$8.274M
YoY Change	59.81%	2200.98%
Income Tax
% Of Pretax Income
Net Earnings	-$11.93M	-$8.274M
YoY Change	54.16%	2200.97%
Net Earnings / Revenue	-10823.84%	-1164.97%
Basic Earnings Per Share	-$0.21	-$0.16
Diluted Earnings Per Share	-$0.21	-$0.16
COMMON SHARES
Basic Shares Outstanding	52.02M shares	51.70M shares
Diluted Shares Outstanding	55.93M shares	51.74M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.418M	$3.282M
YoY Change	-81.0%	-56.2%
Cash & Equivalents	$1.360M	$3.224M
Short-Term Investments	$57.72K	$57.72K
Other Short-Term Assets	$1.529M	$55.69K
YoY Change	152.44%	-91.32%
Inventory	$523.6K	$739.4K
Prepaid Expenses	$1.029M	$1.710M
Receivables	$5.231K	$162.3K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.476M	$5.949M
YoY Change	-57.43%	-35.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$102.9K	$47.22K
YoY Change	232.92%	-68.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$949.0K	$760.7K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.899M	$4.746M
YoY Change	54.77%	148.58%
TOTAL ASSETS
Total Short-Term Assets	$3.476M	$5.949M
Total Long-Term Assets	$4.899M	$4.746M
Total Assets	$8.375M	$10.69M
YoY Change	-26.09%	-3.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.266M	$1.106M
YoY Change	-25.05%	-37.9%
Accrued Expenses	$305.2K	$404.9K
YoY Change	241.96%	-58.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$48.18K	$1.618M
YoY Change	-97.65%	-21.04%
Total Short-Term Liabilities	$1.827M	$3.371M
YoY Change	-57.14%	-32.54%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$665.0K
YoY Change
Other Long-Term Liabilities	$169.5K	$188.9K
YoY Change	-52.76%	-54.34%
Total Long-Term Liabilities	$169.5K	$853.9K
YoY Change	-52.76%	106.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.827M	$3.371M
Total Long-Term Liabilities	$169.5K	$853.9K
Total Liabilities	$1.997M	$4.225M
YoY Change	-56.8%	-21.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$101.6M	-$89.63M
YoY Change	69.25%	71.49%
Common Stock	$59.48K	$52.02K
YoY Change	59.86%	91.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.378M	$6.469M
YoY Change
Total Liabilities & Shareholders Equity	$8.375M	$10.69M
YoY Change	-26.09%	-3.47%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$11.93M	-$8.274M
YoY Change	54.16%	2200.97%
Depreciation, Depletion And Amortization	$109.0K	$104.5K
YoY Change	50.52%	383.57%
Cash From Operating Activities	-$5.440M	-$5.713M
YoY Change	119.27%	810.06%
INVESTING ACTIVITIES
Capital Expenditures	$62.91K	$24.25K
YoY Change	-72.52%	-55.77%
Acquisitions
YoY Change
Other Investing Activities	-$569.7K	$95.73K
YoY Change	-126.61%	-120.38%
Cash From Investing Activities	-$632.6K	$71.48K
YoY Change	-133.09%	-113.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.209M	6.819M
YoY Change	59.49%	3533.48%
NET CHANGE
Cash From Operating Activities	-5.440M	-5.713M
Cash From Investing Activities	-632.6K	71.48K
Cash From Financing Activities	4.209M	6.819M
Net Change In Cash	-1.863M	1.177M
YoY Change	-190.01%	-222.06%
FREE CASH FLOW
Cash From Operating Activities	-$5.440M	-$5.713M
Capital Expenditures	$62.91K	$24.25K
Free Cash Flow	-$5.503M	-$5.737M
YoY Change	103.07%	740.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39569
	dei	Entity Registrant Name EntityRegistrantName	SAFETY SHOT, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2455880
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1061 E. Indiantown Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 110
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33477
	dei	City Area Code CityAreaCode	(561)
	dei	Local Phone Number LocalPhoneNumber	244-7100
CY2023Q4	us-gaap	Cash Cash	3833349	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	842976	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	795824	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1469733	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	55693	usd
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	SHOT	Gain On Sale Of Marketable Securities GainOnSaleOfMarketableSecurities		usd
	SHOT	Gain On Sale Of Marketable Securities GainOnSaleOfMarketableSecurities		usd
CY2023Q2	SHOT	Realized Gainloss On Sale Of Stock RealizedGainlossOnSaleOfStock		usd
	SHOT	Realized Gainloss On Sale Of Stock RealizedGainlossOnSaleOfStock		usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2024Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
CY2024Q1	SHOT	Stock Issued During Period Value Issued From Stock Payable For Services StockIssuedDuringPeriodValueIssuedFromStockPayableForServices		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q2	SHOT	Stock Issued During Period Value Issued Form Stock Payable Services For Services StockIssuedDuringPeriodValueIssuedFormStockPayableServicesForServices		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	SHOT	Fair Value Of Shares Issued For Services Rendered FairValueOfSharesIssuedForServicesRendered		usd
	SHOT	Fair Value Of Shares Issued From Stock Payable FairValueOfSharesIssuedFromStockPayable		usd
	SHOT	Fair Value Of Shares Issued For Employees Bonus FairValueOfSharesIssuedForEmployeesBonus		usd
	SHOT	Fair Value Of Options Granted FairValueOfOptionsGranted		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	SHOT	Gainloss On Sale Of Stock GainlossOnSaleOfStock		usd
	SHOT	Realized Gainloss On Sale Of Marketable Securities RealizedGainlossOnSaleOfMarketableSecurities		usd
	SHOT	Reclassification To Discontinued Operations ReclassificationToDiscontinuedOperations		usd
	SHOT	Reclassification To Assets And Liabilities In Operating Activities Discontinued Operations ReclassificationToAssetsAndLiabilitiesInOperatingActivitiesDiscontinuedOperations		usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
	SHOT	Proceeds From Cash Received For Sale Of Stock ProceedsFromCashReceivedForSaleOfStock		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	SHOT	Proceeds From Shares Issued For Warrant Conversion ProceedsFromSharesIssuedForWarrantConversion		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	SHOT	Reclassification Of Held To Maturity Investments To Marketable Securities ReclassificationOfHeldToMaturityInvestmentsToMarketableSecurities		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	SHOT	Common Stock Issued From Stock Payable On Service CommonStockIssuedFromStockPayableOnService		usd
	SHOT	Common Stock Issued Form Stock Payable On Warrant Conversions CommonStockIssuedFormStockPayableOnWarrantConversions		usd
CY2024Q2	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52016000	shares
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5585	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	86174	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7690824	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	479027	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4511057	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47220	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28272	usd
CY2024Q2	us-gaap	Assets Assets	10694624	usd
CY2023Q4	us-gaap	Assets Assets	12709180	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1106080	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1493809	usd
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1569669	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1500000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	237432	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	214752	usd
CY2024Q2	SHOT	Accrued Interest Current AccruedInterestCurrent	4548	usd
CY2023Q4	SHOT	Accrued Interest Current AccruedInterestCurrent	269152	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	404870	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60450	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	48687	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	48974	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3371286	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3587137	usd
CY2024Q2	SHOT	Loan From Other LoanFromOther	664966	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	188921	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	304907	usd
CY2024Q2	us-gaap	Liabilities Liabilities	4225173	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3892044	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52015949	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52015949	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45634154	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45634154	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	52016	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	45634	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95336033	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	73726987	usd
CY2024Q2	SHOT	Common Stock Payable CommonStockPayable	710882	usd
CY2023Q4	SHOT	Common Stock Payable CommonStockPayable	725230	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89629480	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65680715	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	6469451	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8817136	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10694624	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12709180	usd
CY2024Q2	us-gaap	Revenues Revenues	710240	usd
CY2023Q2	us-gaap	Revenues Revenues	23305	usd
	us-gaap	Revenues Revenues	880972	usd
	us-gaap	Revenues Revenues	58093	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	504528	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	27575	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2887813	usd
	us-gaap	Cost Of Revenue CostOfRevenue	51540	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	205712	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-4270	usd
	us-gaap	Gross Profit GrossProfit	-2006841	usd
	us-gaap	Gross Profit GrossProfit	6553	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8618618	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1741739	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21575170	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2986692	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	8618618	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1741739	usd
	us-gaap	Operating Expenses OperatingExpenses	21575170	usd
	us-gaap	Operating Expenses OperatingExpenses	2986692	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	27183	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	320	usd
	us-gaap	Interest Income Other InterestIncomeOther	31215	usd
	us-gaap	Interest Income Other InterestIncomeOther	689	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	122873	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	11086	usd
	us-gaap	Interest Expense Other InterestExpenseOther	184704	usd
	us-gaap	Interest Expense Other InterestExpenseOther	69638	usd
CY2024Q2	SHOT	Gain On Sale Of Marketable Securities GainOnSaleOfMarketableSecurities	-198046	usd
	SHOT	Gain On Sale Of Marketable Securities GainOnSaleOfMarketableSecurities	-46658	usd
CY2024Q2	SHOT	Realized Gainloss On Sale Of Stock RealizedGainlossOnSaleOfStock	432548	usd
	SHOT	Realized Gainloss On Sale Of Stock RealizedGainlossOnSaleOfStock	432548	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-599155	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1190294	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1190195	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	138812	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1179528	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-366754	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1121246	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8274094	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-566481	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-23948765	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1858893	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-206890	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-191128	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-8274094	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-359591	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23948765	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1667765	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51735158	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25551752	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49581561	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26117310	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3665594	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3450675	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1308174	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5808095	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	220000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-359591	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5668504	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8817136	usd
CY2024Q1	SHOT	Stock Issued During Period Value Due For Services StockIssuedDuringPeriodValueDueForServices	48400	usd
CY2024Q1	SHOT	Stock Issued During Period Value Due On Warrant Conversion StockIssuedDuringPeriodValueDueOnWarrantConversion	2800	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	614500	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	3792215	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	7970134	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15674671	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5570514	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5570514	usd
CY2024Q2	SHOT	Stock Issued During Period Value Issued Form Stock Payable Conv Note Extinguishment StockIssuedDuringPeriodValueIssuedFormStockPayableConvNoteExtinguishment	344196	usd
CY2024Q2	SHOT	Stock Issued During Period Value Due For Services StockIssuedDuringPeriodValueDueForServices	31500	usd
CY2024Q2	SHOT	Stock Issued During Period Value Due On Warrant Conversion StockIssuedDuringPeriodValueDueOnWarrantConversion	-2800	usd
CY2024Q2	SHOT	Stock Issued During Period Value Issued For Employee Bonus StockIssuedDuringPeriodValueIssuedForEmployeeBonus	347500	usd
CY2024Q2	SHOT	Stock Issued During Period Value Issued For Private Placement StockIssuedDuringPeriodValueIssuedForPrivatePlacement	5000000	usd
CY2024Q2	SHOT	Stock Issued During Period Value Warrant Conversions StockIssuedDuringPeriodValueWarrantConversions	154000	usd
CY2024Q2	SHOT	Stock Issued During Period Value Shareholder Investment StockIssuedDuringPeriodValueShareholderInvestment	1000000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2298635	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-8274094	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	6469451	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	6469451	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-23948765	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1858893	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	220000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4663	usd
	us-gaap	Depreciation Depreciation	209002	usd
	us-gaap	Depreciation Depreciation	8362	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	28543	usd
	SHOT	Fair Value Of Shares Issued For Services Rendered FairValueOfSharesIssuedForServicesRendered	694400	usd
	SHOT	Fair Value Of Shares Issued From Stock Payable FairValueOfSharesIssuedFromStockPayable	344196	usd
	SHOT	Fair Value Of Shares Issued For Employees Bonus FairValueOfSharesIssuedForEmployeesBonus	347500	usd
	SHOT	Fair Value Of Options Granted FairValueOfOptionsGranted	10268769	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-599155	usd
	SHOT	Gainloss On Sale Of Stock GainlossOnSaleOfStock	431972	usd
	SHOT	Realized Gainloss On Sale Of Marketable Securities RealizedGainlossOnSaleOfMarketableSecurities	-269723	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-101088	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1166887	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	209621	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	255005	usd
	SHOT	Increase Decrease In Right Of Entry Assets IncreaseDecreaseInRightOfEntryAssets	-87738	usd
	SHOT	Increase Decrease In Right Of Entry Assets IncreaseDecreaseInRightOfEntryAssets	-80860	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	156710	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11187	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-56392	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-31737	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-387729	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	76867	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	149198	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	579412	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-93306	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-74512	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12100942	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2370752	usd
	SHOT	Reclassification To Discontinued Operations ReclassificationToDiscontinuedOperations	191128	usd
	SHOT	Reclassification To Assets And Liabilities In Operating Activities Discontinued Operations ReclassificationToAssetsAndLiabilitiesInOperatingActivitiesDiscontinuedOperations	-191765	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-637	usd
	SHOT	Proceeds From Cash Received For Sale Of Stock ProceedsFromCashReceivedForSaleOfStock	490000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	417445	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	508800	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	24250	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	39100	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	880195	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-469700	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3450675	usd
	SHOT	Proceeds From Shares Issued For Warrant Conversion ProceedsFromSharesIssuedForWarrantConversion	-3946215	usd
	SHOT	Payment Of Loan To Affiliate PaymentOfLoanToAffiliate	-664966	usd
	SHOT	Payment Of Loan To Affiliate PaymentOfLoanToAffiliate	324	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5000000	usd
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	1000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10611181	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3450351	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-609566	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	609262	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3833349	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1477552	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3223783	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2086814	usd
	SHOT	Reclassification Of Held To Maturity Investments To Marketable Securities ReclassificationOfHeldToMaturityInvestmentsToMarketableSecurities	3417100	usd
	us-gaap	Stock Issued1 StockIssued1	245044	usd
	SHOT	Common Stock Issued From Stock Payable On Service CommonStockIssuedFromStockPayableOnService	161900	usd
	SHOT	Common Stock Issued Form Stock Payable On Warrant Conversions CommonStockIssuedFormStockPayableOnWarrantConversions	2800	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89629480	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65680715	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12100942	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10515314	usd
CY2024Q2	us-gaap	Cash Cash	3223783	usd
CY2023Q4	us-gaap	Cash Cash	3833349	usd
CY2024Q2	SHOT	Working Capital WorkingCapital	2577472	usd
CY2023Q4	SHOT	Working Capital WorkingCapital	4303687	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_z9Iyo56a52n1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zYMfYwnbCDyj">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1649473	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-8274094	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-359591	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23948765	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1667765	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51735158	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25551752	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49581561	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26117310	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51735158	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25551752	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49581561	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26117310	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	261404	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36928	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	8658484	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	8658484	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	162295	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5585	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1709835	usd
CY2024Q2	SHOT	Prepaid Orders PrepaidOrders	858977	usd
CY2024Q2	us-gaap	Prepaid Insurance PrepaidInsurance	407857	usd
CY2024Q2	SHOT	Prepaid Raw Materials PrepaidRawMaterials	443001	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1469733	usd
CY2023Q4	SHOT	Prepaid Raw Materials PrepaidRawMaterials	1073823	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	56335	usd
CY2023Q4	SHOT	Prepaid Orders PrepaidOrders	339575	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	739432	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	385125	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	354307	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	795824	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	746663	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	49161	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	5000000	shares
CY2023Q3	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	200000	shares
CY2023Q3	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	5500000	usd
CY2023Q3	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	11000000	usd
CY2023Q3	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2500000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	14000000	usd
CY2023Q3	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	3000000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	203700	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	157443	usd
CY2023Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2200000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	2468500	usd
CY2024Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4548	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	269152	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	404870	usd
CY2024Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	307023	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60450	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	40681	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.79
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1120333	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52015949	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52015949	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45634154	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45634154	shares
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	192000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	15958126	shares
CY2022Q4	SHOT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	1.74
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	14751835	shares
CY2023Q4	SHOT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	2.06
CY2024Q2	SHOT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number One ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumberOne	11801708	shares
CY2024Q2	SHOT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price One ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceOne	3.46
CY2024Q2	SHOT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	11801708	shares
CY2024Q2	SHOT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	3.46
CY2023Q4	us-gaap	Share Price SharePrice	202638
CY2023	SHOT	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Relative Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRelativeFairValue	39444	usd
CY2016Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	870406	usd
CY2016Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	391289	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	237432	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	188921	usd
CY2023Q4	SHOT	Unamortization Expense Operating Lease Right Of Use Asset UnamortizationExpenseOperatingLeaseRightOfUseAsset	479977	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	214752	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	304907	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	19242	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	49010	usd
	us-gaap	Payments For Rent PaymentsForRent	106980	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	213960	usd
CY2023Q4	us-gaap	Shares Issued SharesIssued	330619	shares
CY2023Q4	SHOT	Liquidation Damages LiquidationDamages	2000000	usd
CY2023Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	500000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2105263	shares
CY2024Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	750000	usd
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	600000	usd
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	380000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1656050	shares
CY2024Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	3000000	usd
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	4000000	usd
CY2024Q2	SHOT	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value Of Consideration BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOfConsideration	-58028	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-599155	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	760657	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	599680	usd

Files In Submission

Name	View Source	Status
0001493152-24-032325-index-headers.html	Edgar Link	pending
0001493152-24-032325-index.html	Edgar Link	pending
0001493152-24-032325.txt	Edgar Link	pending
0001493152-24-032325-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shot-20240630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
shot-20240630_cal.xml	Edgar Link	unprocessable
shot-20240630_def.xml	Edgar Link	unprocessable
shot-20240630_lab.xml	Edgar Link	unprocessable
shot-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHOT
Safety Shot, Inc. Stock $shot

2024 Q3 Form 10-Q Financial Statement

#000149315224032325 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHOT Safety Shot, Inc. Stock $shot

2024 Q3 Form 10-Q Financial Statement

#000149315224032325 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHOT
Safety Shot, Inc. Stock $shot